Chemical proteomic profiling with photoaffinity labeling strategy identifies antimalarial targets of artemisinin

被引:0
|
作者
Peng Gao [1 ]
Jiayun Chen [1 ]
Peng Sun [1 ]
Jianyou Wang [2 ]
Huan Tang [1 ]
Fei Xia [1 ]
Liwei Gu [1 ]
Huimin Zhang [3 ]
Chen Wang [1 ]
Yin Kwan Wong [1 ]
Yinhua Zhu [1 ]
Chengchao Xu [1 ]
Jigang Wang [1 ,3 ,4 ]
机构
[1] Artemisinin Research Center,and Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences
[2] Pharmaceutical College,Henan University
[3] Shandong Academy of Chinese Medicine
[4] Department of Nephrology,Shenzhen Key Laboratory of Kidney Diseases,Shenzhen Clinical Research Centre for Geriatrics,Shenzhen People's Hospital,The First Affiliated Hospital,Southern University of Science and Technology
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R531.3 [疟疾]; O657.3 [光化学分析法(光谱分析法)];
学科分类号
070302 ; 081704 ; 1002 ; 100201 ;
摘要
Present research on the antimalarial mechanisms of artemisinin(ART) is mainly focused on covalent drug binding targets alkylated by free radicals, while non-covalent binding targets have rarely been reported.Here, we developed a novel photoaffinity probe of ART to globally capture and identify the antimalarial target proteins of ART through chemical proteomics. The results demonstrated that ART can bind to parasite proteins by both covalent and non-covalent modification, and these may jointly contribute to the antimalarial effects. Our work enriches the research on the antimalarial targets of ART, and provides a new perspective for further exploring the antimalarial mechanism of ART.
引用
收藏
页码:486 / 491
页数:6
相关论文
共 29 条
  • [1] Chemical proteomic profiling with photoaffinity labeling strategy identifies antimalarial targets of artemisinin
    Gao, Peng
    Chen, Jiayun
    Sun, Peng
    Wang, Jianyou
    Tang, Huan
    Xia, Fei
    Gu, Liwei
    Zhang, Huimin
    Wang, Chen
    Wong, Yin Kwan
    Zhu, Yinhua
    Xu, Chengchao
    Wang, Jigang
    CHINESE CHEMICAL LETTERS, 2023, 34 (12)
  • [2] Proteomic profiling of exhausted T cells identifies novel immunotherapeutic targets
    Abdel-Hakeem, Mohamed
    Beusch, Christian
    Ozdilek, Ahmet
    Dawood, Abdelhameed
    Welbourn, Sarah
    Roman, Carly
    Gordon, David
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [3] Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets
    Yuan, Jing
    Cheng, Ken Chih-Chien
    Johnson, Ronald L.
    Huang, Ruili
    Pattaradilokrat, Sittiporn
    Liu, Anna
    Guha, Rajarshi
    Fidock, David A.
    Inglese, James
    Wellems, Thomas E.
    Austin, Christopher P.
    Su, Xin-zhuan
    SCIENCE, 2011, 333 (6043) : 724 - 729
  • [4] Phenotypic proteomic profiling identifies a landscape of targets for circadian clock-modulating compounds
    Ray, Sandipan
    Lach, Radoslaw
    Heesom, Kate J.
    Valekunja, Utham K.
    Encheva, Vesela
    Snijders, Ambrosius P.
    Reddy, Akhilesh B.
    LIFE SCIENCE ALLIANCE, 2019, 2 (06)
  • [5] Differential proteomic profiling identifies novel molecular targets of pterostilbene against experimental diabetes
    Dornadula, Sireesh
    Thiruppathi, Suresh
    Palanisamy, Rajaguru
    Umapathy, Dhamodharan
    Suzuki, Takayoshi
    Mohanram, Ramkumar K.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (03) : 1996 - 2012
  • [6] Quantitative Chemical Proteomic Profiling of the in Vivo Targets of Reactive Drug Metabolites
    Whitby, Landon R.
    Obach, R. Scott
    Simon, Gabriel M.
    Hayward, Matthew M.
    Cravatt, Benjamin F.
    ACS CHEMICAL BIOLOGY, 2017, 12 (08) : 2040 - 2050
  • [7] Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer
    Xu, Ganfei
    Huang, Rui
    Wumaier, Reziya
    Lyu, Jiacheng
    Huang, Minjing
    Zhang, Yaya
    Chen, Qingjian
    Liu, Wenting
    Tao, Mengyu
    Li, Junjian
    Tao, Zhonghua
    Yu, Bo
    Xu, Erxiang
    Wang, Lingfeng
    Yu, Guoying
    Gires, Olivier
    Zhou, Lei
    Zhu, Wei
    Ding, Chen
    Wang, Hongxia
    CANCER RESEARCH, 2024, 84 (19) : 3267 - 3285
  • [8] Chemical proteomic strategy for the identification of druggable kinase targets in Trypanosoma brucei
    Perera, B. Gayani K.
    Brigham, Jennifer
    Ojo, Kayode K.
    Van Voorhis, Wesley C.
    Maly, Dustin J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [9] Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets
    Ti’ara L. Griffen
    Fieke W. Hoff
    Yihua Qiu
    James W. Lillard
    Alessandra Ferrajoli
    Philip Thompson
    Endurance Toro
    Kevin Ruiz
    Jan Burger
    William Wierda
    Steven M. Kornblau
    Blood Cancer Journal, 12
  • [10] Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets
    Gates, Leah A.
    Gu, Guowei
    Chen, Yue
    Rohira, Aarti D.
    Lei, Jonathan T.
    Hamilton, Ross A.
    Yu, Yang
    Lonard, David M.
    Wang, Jin
    Wang, Shu-Ping
    Edwards, David G.
    Lavere, Philip F.
    Shao, Jiangyong
    Yi, Ping
    Jain, Antrix
    Jung, Sung Yun
    Malovannaya, Anna
    Li, Shunqiang
    Shao, Jieya
    Roeder, Robert G.
    Ellis, Matthew J.
    Qin, Jun
    Fuqua, Suzanne A. W.
    O'Malley, Bert W.
    Foulds, Charles E.
    ONCOGENE, 2018, 37 (33) : 4581 - 4598